These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33365027)

  • 1. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 2. The 49th Annual Meeting of the Japanese Society for Immunology: COVID-19 and Immunity.
    Shinkura R; Kang S; Arase H; Toyama-Sorimachi N
    Int Immunol; 2021 Mar; 33(4):193-196. PubMed ID: 33538811
    [No Abstract]   [Full Text] [Related]  

  • 3. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
    Alikhani M; Javadi A; Aalikhani M
    Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
    Tauber AL; Schweiker SS; Levonis SM
    Future Med Chem; 2021 Mar; 13(6):587-592. PubMed ID: 33467912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
    Bellgrau D; Modiano JF
    Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Responses to the Novel Coronavirus-2: Friend or Foe?
    Mahmoodpoor A; Nader ND
    Immunol Invest; 2021 Nov; 50(8):949-951. PubMed ID: 32689852
    [No Abstract]   [Full Text] [Related]  

  • 8. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
    Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.
    Liao WH; Yang GG; Henneberg M
    Swiss Med Wkly; 2020 Nov; 150():w20444. PubMed ID: 33306813
    [No Abstract]   [Full Text] [Related]  

  • 13. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Shabbir S; Raza MH; Arshad M; Khan MJ
    Arch Virol; 2021 Aug; 166(8):2109-2117. PubMed ID: 33950288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis.
    Giamarellos-Bourboulis EJ
    EBioMedicine; 2021 Nov; 73():103673. PubMed ID: 34742130
    [No Abstract]   [Full Text] [Related]  

  • 15. What triggers severe COVID? Infected immune cells hold clues.
    Mallapaty S
    Nature; 2022 Apr; 604(7905):231. PubMed ID: 35388153
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
    Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
    Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
    [No Abstract]   [Full Text] [Related]  

  • 18. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
    Peng X; Ouyang J; Isnard S; Lin J; Fombuena B; Zhu B; Routy JP
    Front Immunol; 2020; 11():596631. PubMed ID: 33384690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection.
    Battina HL; Alentado VJ; Srour EF; Moliterno AR; Kacena MA
    Exp Hematol; 2021 Dec; 104():32-39. PubMed ID: 34563606
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.